Annual Cash & Cash Equivalents
$139.04 M
-$4.90 M-3.41%
December 31, 2024
Summary
- As of March 12, 2025, TSHA annual cash & cash equivalents is $139.04 million, with the most recent change of -$4.90 million (-3.41%) on December 31, 2024.
- During the last 3 years, TSHA annual cash & cash equivalents has fallen by -$10.07 million (-6.75%).
- TSHA annual cash & cash equivalents is now -44.66% below its all-time high of $251.25 million, reached on December 31, 2020.
Performance
TSHA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$139.04 M
-$18.65 M-11.83%
December 31, 2024
Summary
- As of March 12, 2025, TSHA quarterly cash and cash equivalents is $139.04 million, with the most recent change of -$18.65 million (-11.83%) on December 31, 2024.
- Over the past year, TSHA quarterly cash and cash equivalents has stayed the same.
- TSHA quarterly cash and cash equivalents is now -50.10% below its all-time high of $278.63 million, reached on September 30, 2020.
Performance
TSHA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TSHA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.4% | 0.0% |
| 3 y3 years | -6.8% | 0.0% |
| 5 y5 years | +100.0% | 0.0% |
TSHA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.8% | +58.2% | -19.5% | +305.3% |
| 5 y | 5-year | -44.7% | -100.0% | -50.1% | +1141.4% |
| alltime | all time | -44.7% | -100.0% | -50.1% | +1141.4% |
Taysha Gene Therapies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $139.04 M(-3.4%) | $139.04 M(-11.8%) |
| Sep 2024 | - | $157.69 M(-8.7%) |
| Jun 2024 | - | $172.74 M(+39.3%) |
| Mar 2024 | - | $123.98 M(-13.9%) |
| Dec 2023 | $143.94 M(+63.8%) | $143.94 M(-12.4%) |
| Sep 2023 | - | $164.28 M(+264.4%) |
| Jun 2023 | - | $45.08 M(-28.9%) |
| Mar 2023 | - | $63.42 M(-27.8%) |
| Dec 2022 | $87.88 M | $87.88 M(+156.2%) |
| Sep 2022 | - | $34.31 M(-48.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $66.24 M(-31.5%) |
| Mar 2022 | - | $96.63 M(-35.2%) |
| Dec 2021 | $149.10 M(-40.7%) | $149.10 M(-21.0%) |
| Sep 2021 | - | $188.78 M(-4.3%) |
| Jun 2021 | - | $197.37 M(-13.7%) |
| Mar 2021 | - | $228.68 M(-9.0%) |
| Dec 2020 | $251.25 M(>+9900.0%) | - |
| Dec 2020 | - | $251.25 M(-9.8%) |
| Sep 2020 | - | $278.63 M(+2387.8%) |
| Jun 2020 | - | $11.20 M |
| Dec 2019 | $0.00 | - |
FAQ
- What is Taysha Gene Therapies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual cash & cash equivalents year-on-year change?
- What is Taysha Gene Therapies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly cash and cash equivalents year-on-year change?
What is Taysha Gene Therapies annual cash & cash equivalents?
The current annual cash & cash equivalents of TSHA is $139.04 M
What is the all time high annual cash & cash equivalents for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual cash & cash equivalents is $251.25 M
What is Taysha Gene Therapies annual cash & cash equivalents year-on-year change?
Over the past year, TSHA annual cash & cash equivalents has changed by -$4.90 M (-3.41%)
What is Taysha Gene Therapies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TSHA is $139.04 M
What is the all time high quarterly cash and cash equivalents for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly cash and cash equivalents is $278.63 M
What is Taysha Gene Therapies quarterly cash and cash equivalents year-on-year change?
Over the past year, TSHA quarterly cash and cash equivalents has changed by $0.00 (0.00%)